Omega Healthcare Investors (NYSE:OHI) updated its fourth quarter 2019 earnings guidance on Tuesday. The company provided earnings per share guidance of $0.76-0.79 for the period. Omega Healthcare Investors also updated its FY 2019 guidance to $3.03-3.07 EPS.
Shares of Omega Healthcare Investors stock traded up $0.27 on Friday, hitting $38.68. 2,913,088 shares of the company’s stock traded hands, compared to its average volume of 1,656,198. The firm has a 50-day moving average price of $37.08. The company has a market cap of $7.94 billion, a PE ratio of 12.72, a PEG ratio of 4.72 and a beta of 0.42. Omega Healthcare Investors has a one year low of $31.00 and a one year high of $40.30. The company has a quick ratio of 2.86, a current ratio of 2.86 and a debt-to-equity ratio of 1.16.
Omega Healthcare Investors (NYSE:OHI) last posted its quarterly earnings data on Tuesday, August 6th. The real estate investment trust reported $0.34 EPS for the quarter, missing the Zacks’ consensus estimate of $0.73 by ($0.39). The business had revenue of $191.81 million for the quarter, compared to analyst estimates of $190.46 million. Omega Healthcare Investors had a return on equity of 6.91% and a net margin of 29.38%. The company’s quarterly revenue was down .5% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.75 earnings per share. Research analysts expect that Omega Healthcare Investors will post 2.99 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Thursday, August 15th. Stockholders of record on Wednesday, July 31st will be issued a dividend of $0.66 per share. The ex-dividend date is Tuesday, July 30th. This represents a $2.64 annualized dividend and a dividend yield of 6.83%. Omega Healthcare Investors’s dividend payout ratio is presently 86.84%.
Several analysts recently issued reports on OHI shares. Raymond James upgraded shares of Omega Healthcare Investors from an outperform rating to a strong-buy rating and increased their price target for the stock from $40.00 to $42.00 in a research report on Thursday. Zacks Investment Research upgraded shares of Omega Healthcare Investors from a hold rating to a buy rating and set a $42.00 target price on the stock in a research report on Wednesday, July 31st. Five equities research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has given a strong buy rating to the stock. The company has an average rating of Buy and an average price target of $38.77.
In other Omega Healthcare Investors news, CFO Robert O. Stephenson sold 10,000 shares of the firm’s stock in a transaction that occurred on Monday, May 13th. The shares were sold at an average price of $37.00, for a total value of $370,000.00. Following the sale, the chief financial officer now owns 233,326 shares in the company, valued at $8,633,062. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO C Taylor Pickett sold 30,000 shares of the firm’s stock in a transaction that occurred on Monday, June 24th. The shares were sold at an average price of $38.00, for a total transaction of $1,140,000.00. Following the completion of the sale, the chief executive officer now owns 269,133 shares in the company, valued at approximately $10,227,054. The disclosure for this sale can be found here. Insiders sold 85,500 shares of company stock worth $3,239,000 in the last 90 days. Company insiders own 1.16% of the company’s stock.
Omega Healthcare Investors Company Profile
Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.
Further Reading: Bid-Ask Spread
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.